G. Germano, R. Frapolli, M. Simone, M. Tavecchio, E. Erba et al., Antitumor and Anti-inflammatory Effects of Trabectedin on Human Myxoid Liposarcoma Cells, Antitumor and antiinflammatory effects of trabectedin on human myxoid liposarcoma cells, pp.2235-2244, 2010.
DOI : 10.1158/0008-5472.CAN-09-2335

N. Kumari, B. S. Dwarakanath, A. Das, and A. N. Bhatt, Role of interleukin-6 in cancer progression and therapeutic resistance, Tumor Biology, vol.484, issue.1, pp.11553-11572, 2016.
DOI : 10.1016/S0014-5793(00)02115-3

J. Gao, S. Zhao, and T. S. Halstensen, Increased interleukin-6 expression is associated with poor prognosis and acquired cisplatin resistance in head and neck squamous cell carcinoma, Oncology Reports, vol.35, issue.6, pp.3265-3274, 2016.
DOI : 10.3892/or.2016.4765

T. H. Heo, J. Wahler, and N. Suh, Potential therapeutic implications of IL-6/IL-6R/gp130-targeting agents in breast cancer, Oncotarget, vol.7, issue.13, pp.15460-15473, 2016.
DOI : 10.18632/oncotarget.7102

M. E. Schmidt, A. Meynkohn, N. Habermann, J. Wiskemann, J. Oelmann et al., Resistance Exercise and Inflammation in Breast Cancer Patients Undergoing Adjuvant Radiation Therapy: Mediation Analysis From a Randomized, Controlled Intervention Trial, International Journal of Radiation Oncology*Biology*Physics, vol.94, issue.2, pp.329-337, 2016.
DOI : 10.1016/j.ijrobp.2015.10.058

J. Goh, E. Endicott, and W. C. Ladiges, Pre-tumor exercise decreases breast cancer in old mice in a distance-dependent manner, Am J Cancer Res, vol.4, pp.378-384, 2014.

A. M. Dennett, C. L. Peiris, N. Shields, L. A. Prendergast, and N. F. Taylor, Moderate-intensity exercise reduces fatigue and improves mobility in cancer survivors: a systematic review and meta-regression, Journal of Physiotherapy, vol.62, issue.2, pp.62-68, 2016.
DOI : 10.1016/j.jphys.2016.02.012

E. L. Richman, S. A. Kenfield, M. J. Stampfer, A. Paciorek, P. R. Carroll et al., Physical Activity after Diagnosis and Risk of Prostate Cancer Progression: Data from the Cancer of the Prostate Strategic Urologic Research Endeavor, Cancer Research, vol.71, issue.11, pp.71-3889, 2011.
DOI : 10.1158/0008-5472.CAN-10-3932

J. J. Peterson, M. J. Kransdorf, L. W. Bancroft, and M. I. Connor, Malignant fatty tumors: classification, clinical course, imaging appearance and treatment, Skeletal Radiology, vol.32, issue.9, pp.32-493, 2003.
DOI : 10.1007/s00256-003-0647-8

T. Ariizumi, A. Ogose, H. Kawashima, T. Hotta, G. Li et al., Establishment and characterization of a novel dedifferentiated liposarcoma cell line, Pathol Int, issue.1, pp.61-461, 2011.

D. D. Hershko, B. W. Robb, G. Luo, and P. O. Hasselgren, Multiple transcription factors regulating the IL-6 gene are activated by cAMP in cultured Caco-2 cells, American Journal of Physiology - Regulatory, Integrative and Comparative Physiology, vol.283, issue.5, pp.1140-1148, 2002.
DOI : 10.1152/ajpregu.00161.2002

M. I. Lefterova, Y. Zhang, D. J. Steger, M. Schupp, J. Schug et al., PPAR?? and C/EBP factors orchestrate adipocyte biology via adjacent binding on a genome-wide scale, Genes & Development, vol.22, issue.21, pp.2941-2952, 2008.
DOI : 10.1101/gad.1709008

URL : http://genesdev.cshlp.org/content/22/21/2941.full.pdf

M. Assi, F. Derbre, L. Lefeuvre-orfila, D. Saligaut, N. Stock et al., Maintaining a regular physical activity aggravates intramuscular tumor growth in an orthotopic liposarcoma model, Am J Cancer Res, vol.7, pp.1037-1053, 2017.
URL : https://hal.archives-ouvertes.fr/hal-01544192

L. M. Coussens and Z. Werb, Inflammation and cancer, Nature, vol.2, issue.6917, pp.860-867, 2002.
DOI : 10.1091/mbc.9.4.875

Z. Tang, Q. Shen, H. Xie, X. Zhou, J. Li et al., Elevated expression of FABP3 and FABP4 cooperatively correlates with poor prognosis in non-small cell lung cancer (NSCLC), Oncotarget, vol.7, issue.29, pp.46253-46262, 2016.
DOI : 10.18632/oncotarget.10086

L. Pedersen, M. Idorn, G. H. Olofsson, B. Lauenborg, I. Nookaew et al., Voluntary Running Suppresses Tumor Growth through Epinephrine- and IL-6-Dependent NK Cell Mobilization and Redistribution, Cell Metabolism, vol.23, issue.3, pp.554-562, 2016.
DOI : 10.1016/j.cmet.2016.01.011

URL : https://doi.org/10.1016/j.cmet.2016.01.011

R. D. Harvey and E. T. Morgan, Cancer, Inflammation, and Therapy: Effects on Cytochrome P450???Mediated Drug Metabolism and Implications for Novel Immunotherapeutic Agents, Clinical Pharmacology & Therapeutics, vol.878, issue.4, pp.449-457, 2014.
DOI : 10.1016/j.jchromb.2009.11.023

V. Poli, The Role of C/EBP Isoforms in the Control of Inflammatory and Native Immunity Functions, Journal of Biological Chemistry, vol.18, issue.45, pp.29279-29282, 1998.
DOI : 10.1128/MCB.18.7.4301

G. D. Lu, C. H. Leung, B. Yan, C. M. Tan, S. Y. Low et al., C/EBP?? Is Up-regulated in a Subset of Hepatocellular Carcinomas and Plays a Role in Cell Growth and Proliferation, Gastroenterology, vol.139, issue.2, pp.632-643, 2010.
DOI : 10.1053/j.gastro.2010.03.051

T. Milde-langosch, A. M. Loning, and . Bamberger, Expression of the CCAAT/Enhancer-Binding Proteins C/EBP??, C/EBP?? and C/EBP?? in Breast Cancer: Correlations with Clinicopathologic Parameters and Cell-Cycle Regulatory Proteins, Breast Cancer Research and Treatment, vol.86, issue.2, pp.175-185, 2003.
DOI : 10.1038/bjc.1998.739

K. Sundfeldt, K. Ivarsson, M. Carlsson, S. Enerback, P. O. Janson et al., The expression of CCAAT/enhancer binding protein (C/EBP) in the human ovary in vivo: specific increase in C/EBP?? during epithelial tumour progression, British Journal of Cancer, vol.79, issue.7-8, pp.1240-1248, 1999.
DOI : 10.1038/sj.bjc.6690199

G. D. Lu, Y. H. Ang, J. Zhou, J. Tamilarasi, B. Yan et al., CCAAT/enhancer binding protein ?? predicts poorer prognosis and prevents energy starvation-induced cell death in hepatocellular carcinoma, Hepatology, vol.8, issue.3, pp.965-978, 2015.
DOI : 10.1002/cncr.27758

URL : http://onlinelibrary.wiley.com/doi/10.1002/hep.27593/pdf

J. K. Hamm, B. H. Park, and S. R. Farmer, A Role for C/EBP?? in Regulating Peroxisome Proliferator-activated Receptor ?? Activity during Adipogenesis in 3T3-L1 Preadipocytes, Journal of Biological Chemistry, vol.275, issue.32, pp.18464-18471, 2001.
DOI : 10.1093/emboj/16.24.7432

M. Tamura, S. Sebastian, S. Yang, B. Gurates, Z. Fang et al., Induction of cyclooxygenase-2 in human endometrial stromal cells by malignant endometrial epithelial cells: evidence for the involvement of extracellularly regulated kinases and CCAAT/enhancer binding proteins, Journal of Molecular Endocrinology, vol.31, issue.1, pp.31-95, 2003.
DOI : 10.1677/jme.0.0310095

K. Rask, M. Thorn, F. Ponten, W. Kraaz, K. Sundfeldt et al., Increased expression of the transcription factors CCAAT-enhancer binding protein-? (C/EB?) and C/EBP? (CHOP) correlate with invasiveness of human colorectal cancer, International Journal of Cancer, vol.89, issue.3, pp.337-343, 2000.
DOI : 10.1016/B978-0-12-487425-1.50008-5

F. S. Forootan, S. S. Forootan, X. Gou, J. Yang, B. Liu et al., Fatty acid activated PPAR&#x03B3; promotes tumorigenicity of prostate cancer cells by up regulating <i>VEGF</i> via PPAR responsive elements of the promoter, Oncotarget, vol.7, issue.8, pp.9322-9339, 2016.
DOI : 10.18632/oncotarget.6975

I. K. Choi, Y. H. Kim, J. S. Kim, and J. H. Seo, PPAR-?? ligand promotes the growth of APC-mutated HT-29 human colon cancer cells in vitro and in vivo, Investigational New Drugs, vol.102, issue.Suppl, pp.283-288, 2008.
DOI : 10.1007/s10637-007-9108-x

A. Takeuchi, N. Yamamoto, T. Shirai, K. Hayashi, S. Miwa et al., Clinical relevance of peroxisome proliferator-activated receptor-gamma expression in myxoid liposarcoma, BMC Cancer, vol.9, issue.1, pp.16-442, 2016.
DOI : 10.1371/journal.pone.0093996

S. Endo, K. Nakata, K. Ohuchida, S. Takesue, H. Nakayama et al., Associated With Pancreatic Cancer Progression and Promotes Growth of Pancreatic Tumors in Mice, Autophagy Is Required for Activation of Pancreatic Stellate Cells Gastroenterology, vol.152, pp.1492-1506, 2017.

L. Guo, J. X. Huang, Y. Liu, X. Li, S. R. Zhou et al., Transactivation of Atg4b by C/EBP?? Promotes Autophagy To Facilitate Adipogenesis, Molecular and Cellular Biology, vol.33, issue.16, pp.3180-3190, 2013.
DOI : 10.1128/MCB.00193-13

D. J. Barakat, J. Mendonca, T. Barberi, J. Zhang, S. K. Kachhap et al., EBPbeta regulates sensitivity to bortezomib in prostate cancer cells by inducing REDD1 and autophagosome-lysosome fusion, Cancer Lett, pp.375-152, 2016.

J. Zhou, W. Zhang, B. Liang, M. C. Casimiro, D. Whitaker-menezes et al., PPAR?? activation induces autophagy in breast cancer cells, PPARgamma activation induces autophagy in breast cancer cells, pp.2334-2342, 2009.
DOI : 10.1016/j.biocel.2009.06.007

C. Nerlov, The C/EBP family of transcription factors: a paradigm for interaction between gene expression and proliferation control, Trends in Cell Biology, vol.17, issue.7, pp.318-324, 2007.
DOI : 10.1016/j.tcb.2007.07.004

A. Jakobs, S. Uttarkar, C. Schomburg, S. Steinmann, A. Coulibaly et al., An isoform-specific C/EBPbeta inhibitor targets acute myeloid leukemia cells, Leukemia, vol.30, pp.1612-1615, 2016.
DOI : 10.1038/leu.2016.16

Y. V. Wu, T. Okada, P. Decarolis, N. Socci, R. O-'connor et al., Restoration of C/EBP?? in dedifferentiated liposarcoma induces G2/M cell cycle arrest and apoptosis, Genes, Chromosomes and Cancer, vol.281, issue.4, pp.313-327, 2012.
DOI : 10.1074/jbc.M510682200